Balyasny Asset Management Portfolio holdings
AUM
$44B
1-Year Return
17.37%
This Quarter Return
+0.83%
1 Year Return
+17.37%
3 Year Return
+72.12%
5 Year Return
+152.69%
10 Year Return
+378.29%
AUM
$38.7B
AUM Growth
-$288M
(-0.74%)
Cap. Flow
-$770M
Cap. Flow
% of AUM
-1.99%
Top 10 Holdings %
Top 10 Hldgs %
10.53%
Holding
2,583
New
583
Increased
631
Reduced
609
Closed
644
Top Buys
| 1 |
Apple
AAPL
|
+$502M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$448M |
| 3 |
Wells Fargo
WFC
|
+$282M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$272M |
| 5 |
ConocoPhillips
COP
|
+$220M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$777M |
| 2 |
TSMC
TSM
|
+$353M |
| 3 |
Meta Platforms (Facebook)
META
|
+$329M |
| 4 |
JPMorgan Chase
JPM
|
+$255M |
| 5 |
ASML
ASML
|
+$246M |
Sector Composition
| 1 | Industrials | 14.08% |
| 2 | Consumer Discretionary | 13.79% |
| 3 | Financials | 12.94% |
| 4 | Technology | 12.76% |
| 5 | Healthcare | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Liquidia Corp
LQDA
$2.32B
| $123K | ﹤0.01% |
+10,250
| New | +$123K |
|
1727
Cognyte Software
CGNT
$636M
| $123K | ﹤0.01% |
+16,043
| New | +$123K |
|
1728
AngioDynamics
ANGO
$445M
| $118K | ﹤0.01% |
19,545
-5,542
| -22% | -$33.5K |
|
1729
Safe Bulkers
SB
$458M
| $113K | ﹤0.01% |
+19,438
| New | +$113K |
|
|
CEPU
1730
Central Puerto
CEPU
$1.35B
| $113K | ﹤0.01% |
+12,454
| New | +$113K |
|
1731
Savara
SVRA
$620M
| $112K | ﹤0.01% |
+27,833
| New | +$112K |
|
1732
3D Systems Corporation
DDD
$289M
| $108K | ﹤0.01% |
+35,037
| New | +$108K |
|
1733
Patterson-UTI
PTEN
$2.14B
| $106K | ﹤0.01% |
10,253
-2,806,077
| -100% | -$29.1M |
|
1734
Adaptive Biotechnologies
ADPT
$2.05B
| $106K | ﹤0.01% |
29,227
+9,341
| +47% | +$33.8K |
|
|
DRD
1735
DRDGold
DRD
$1.97B
| $104K | ﹤0.01% |
+12,132
| New | +$104K |
|
1736
AbCellera Biologics
ABCL
$1.38B
| $103K | ﹤0.01% |
34,794
-23,716
| -41% | -$70.2K |
|
1737
Anavex Life Sciences
AVXL
$823M
| $103K | ﹤0.01% |
24,349
-58,731
| -71% | -$248K |
|
1738
Teladoc Health
TDOC
$1.37B
| $101K | ﹤0.01% |
10,311
-831,619
| -99% | -$8.13M |
|
1739
Rumble
RUM
$2.48B
| $99.8K | ﹤0.01% |
17,976
-32,766
| -65% | -$182K |
|
1740
Heron Therapeutics
HRTX
$196M
| $94K | ﹤0.01% |
+26,868
| New | +$94K |
|
|
QVCGA
1741
QVC Group, Inc. Series A Common Stock
QVCGA
$87.4M
| $90.9K | ﹤0.01% |
2,886
-2,955
| -51% | -$93.1K |
|
1742
Cytek Biosciences
CTKB
$525M
| $90.6K | ﹤0.01% |
16,238
-29,529
| -65% | -$165K |
|
1743
Sera Prognostics
SERA
$117M
| $90.2K | ﹤0.01% |
15,232
-4,727
| -24% | -$28K |
|
1744
Stem
STEM
$122M
| $86.6K | ﹤0.01% |
+3,903
| New | +$86.6K |
|
1745
Caribou Biosciences
CRBU
$178M
| $86K | ﹤0.01% |
52,419
-110,264
| -68% | -$181K |
|
|
EMX
1746
EMX Royalty
EMX
$456M
| $85.7K | ﹤0.01% |
+47,620
| New | +$85.7K |
|
1747
NovaGold Resources
NG
$2.84B
| $84.4K | ﹤0.01% |
+24,392
| New | +$84.4K |
|
1748
FuelCell Energy
FCEL
$209M
| $82.9K | ﹤0.01% |
4,325
+3,532
| +445% | +$67.7K |
|
1749
Alignment Healthcare
ALHC
$3.24B
| $81.7K | ﹤0.01% |
+10,442
| New | +$81.7K |
|
1750
MBIA
MBI
$386M
| $81.4K | ﹤0.01% |
14,832
-16,634
| -53% | -$91.3K |
|